Possible sites of action of the new calcitonin gene-related peptide receptor antagonists

Keyphrases

• Calcitonin Gene-related Peptide 100%
• Site of Action 100%
• Migraine 30%
• Calcitonin Receptor 30%
• Acute Migraine 20%
• Vasodilatation 20%
• Migraine Attack 20%
• Brainstem 20%
• Smooth muscle Cells 20%
• Midbrain 10%
• Clinical Efficacy 10%
• Central Nervous System 10%
• Vasodilator 10%
• Migraine Treatment 10%
• Trigeminal Ganglion 10%
• Trigeminal System 10%
• Acute Treatment 10%
• Intracranial Artery 10%
• Nervous System 10%
• Peripheral Nervous System 10%
• Therapeutic Use 10%
• Synapse 10%
• Receptor Activity-modifying Protein 10%
• Localization Studies 10%
• Central Synapses 10%
• Second-order Neuron 10%
• Neurovascular Disease 10%
• Large-sized 10%

Neuroscience

• Calcitonin 100%
• Calcitonin Gene-Related Peptide Receptor Antagonist 100%
• Migraine 85%
• Eicosanoid Receptor 28%
• Synapse 28%
• Calcitonin Gene-Related Peptide Receptor 28%
• Brainstem 28%
• Midbrain 14%
• Central Nervous System 14%
• Trigeminal Ganglion 14%
• Vasoconstrictors 14%
• Nervous System 14%
• Peripheral Nervous System 14%
• RAMP1 14%
• Calcitonin Receptor Like Receptor 14%